The global CRISPR gene editing market was valued at $846.2 million in 2019 and is projected to reach $10,825.1 million by 2030, registering a compound annual growth rate of 26.86% during the forecast. This is according to the forecast report of Research and Markets.
Demand for high-quality food, innovative medicine expands global market for CRISPR gene editing
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.
Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.
Outbreak Daily Digest
The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
- Anti-biotechnology critics say the Genetic Literacy Project is a Monsanto-funded ‘corporate front’. It’s not true. Here is the documentation — and a review of the critics behind the disinformation
- ‘Holy sh–, it works’: How an out-of-the-box UK COVID recovery trial evaluating a common drug has saved a million lives
- Top China virologist who conducts risky experiments in Wuhan with bat coronaviruses rejects lab leak theory
- Farmers warn Mexico’s GM corn ban will raise food prices
- Viewpoint: Is Bill Gates the point man for ‘taking over’ the world’s food supply in service of Big Agriculture?
- Video: 10 of the most prominent anti-vaccine celebrities, from Jim Carrey to Jenny McCarthy
- Homo sapiens reevaluated: Why the definition of ‘modern human’ is undergoing a revamp
- Viewpoint: Is aquaculture good for the planet? Here’s a carbon footprint sustainability snapshot
- What are “Superweeds”?
- After a fertility clinic freezer filled with 3,500 frozen eggs and embryos malfunctioned, many families lost their only chance at having kids. A jury just awarded them $15 million in damages